Three developments I’m watching today: new research on how social disadvantage interacts with the long-term health risks of early menopause, a USD 152 million biotech financing that shows where investors are willing to deploy substantial capital, and healthcare M&A rising sharply even as venture funding remains more subdued.
Menopause Competition Heats Up as Biotech’s Exit Market Strengthens
The Daily Capital Briefing — 12 August 2026
Keep reading with a 7-day free trial
Subscribe to The Billion Dollar Blindspot to keep reading this post and get 7 days of free access to the full post archives.